These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34992112)

  • 21. Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis.
    Carla A; Pereira B; Boukail H; Audard J; Pinol-Domenech N; De Carvalho M; Blondonnet R; Zhai R; Morand D; Lambert C; Sapin V; Ware LB; Calfee CS; Bastarache JA; Laffey JG; Juffermans NP; Bos LD; Artigas A; Rocco PRM; Matthay MA; McAuley DF; Constantin JM; Jabaudon M;
    Respir Res; 2020 Apr; 21(1):81. PubMed ID: 32264897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host-Response Subphenotypes Offer Prognostic Enrichment in Patients With or at Risk for Acute Respiratory Distress Syndrome.
    Kitsios GD; Yang L; Manatakis DV; Nouraie M; Evankovich J; Bain W; Dunlap DG; Shah F; Barbash IJ; Rapport SF; Zhang Y; DeSensi RS; Weathington NM; Chen BB; Ray P; Mallampalli RK; Benos PV; Lee JS; Morris A; McVerry BJ
    Crit Care Med; 2019 Dec; 47(12):1724-1734. PubMed ID: 31634231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Machine Learning for Clinical Subphenotype Identification in Sepsis.
    Hu C; Li Y; Wang F; Peng Z
    Infect Dis Ther; 2022 Oct; 11(5):1949-1964. PubMed ID: 36006560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarker-Based Classification of Patients With Acute Respiratory Failure Into Inflammatory Subphenotypes: A Single-Center Exploratory Study.
    Drohan CM; Nouraie SM; Bain W; Shah FA; Evankovich J; Zhang Y; Morris A; McVerry BJ; Kitsios GD
    Crit Care Explor; 2021 Aug; 3(8):e0518. PubMed ID: 34476405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): study protocol for a randomized controlled trial.
    ART Investigators
    Trials; 2012 Aug; 13():153. PubMed ID: 22929542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Ratio of Partial Pressure Arterial Oxygen and Fraction of Inspired Oxygen 1 Day After Acute Respiratory Distress Syndrome Onset Can Predict the Outcomes of Involving Patients.
    Lai CC; Sung MI; Liu HH; Chen CM; Chiang SR; Liu WL; Chao CM; Ho CH; Weng SF; Hsing SC; Cheng KC
    Medicine (Baltimore); 2016 Apr; 95(14):e3333. PubMed ID: 27057912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The discovery of biological subphenotypes in ARDS: a novel approach to targeted medicine?
    Wildi K; Livingstone S; Palmieri C; LiBassi G; Suen J; Fraser J
    J Intensive Care; 2021 Jan; 9(1):14. PubMed ID: 33478589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of molecular subphenotypes in two cohorts of paediatric ARDS.
    Yehya N; Zinter MS; Thompson JM; Lim MJ; Hanudel MR; Alkhouli MF; Wong H; Alder MN; McKeone DJ; Halstead ES; Sinha P; Sapru A
    Thorax; 2024 Jan; 79(2):128-134. PubMed ID: 37813544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of different transpulmonary pressures guided mechanical ventilation on respiratory and hemodynamics of patients with ARDS: a prospective randomized controlled trial].
    Li J; Luo Z; Li X; Huang Z; Han J; Li Z; Zhou Z; Chen H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):39-44. PubMed ID: 28459402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quality of results of therapy of acute respiratory failure : changes over a period of two decades].
    Briegel I; Dolch M; Irlbeck M; Hauer D; Kaufmann I; Schelling G
    Anaesthesist; 2013 Apr; 62(4):261-70. PubMed ID: 23558717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapidly Improving ARDS in Therapeutic Randomized Controlled Trials.
    Schenck EJ; Oromendia C; Torres LK; Berlin DA; Choi AMK; Siempos II
    Chest; 2019 Mar; 155(3):474-482. PubMed ID: 30359616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
    Ranieri VM; Pettilä V; Karvonen MK; Jalkanen J; Nightingale P; Brealey D; Mancebo J; Ferrer R; Mercat A; Patroniti N; Quintel M; Vincent JL; Okkonen M; Meziani F; Bellani G; MacCallum N; Creteur J; Kluge S; Artigas-Raventos A; Maksimow M; Piippo I; Elima K; Jalkanen S; Jalkanen M; Bellingan G;
    JAMA; 2020 Feb; 323(8):725-733. PubMed ID: 32065831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
    Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
    Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent severe acute respiratory distress syndrome for the prognostic enrichment of trials.
    Sanchez E; Price DR; Chung KP; Oromendia C; Choi AMK; Schenck EJ; Siempos II
    PLoS One; 2020; 15(1):e0227346. PubMed ID: 31986174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatment.
    Liu X; Jiang Y; Jia X; Ma X; Han C; Guo N; Peng Y; Liu H; Ju Y; Luo X; Li X; Bu Y; Zhang J; Liu Y; Gao Y; Zhao M; Wang H; Luo L; Yu K; Wang C
    Crit Care; 2021 Aug; 25(1):320. PubMed ID: 34461969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological subphenotypes of acute respiratory distress syndrome may not reflect differences in alveolar inflammation.
    Heijnen NFL; Hagens LA; Smit MR; Schultz MJ; van der Poll T; Schnabel RM; van der Horst ICC; Dickson RP; Bergmans DCJJ; Bos LDJ;
    Physiol Rep; 2021 Feb; 9(3):e14693. PubMed ID: 33547768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk factors analysis of acute respiratory distress syndrome in intensive care unit traumatic patients].
    Li X; Yu J; Huang W; Huang Q; Yan J; Liang H; Sun Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Oct; 30(10):978-982. PubMed ID: 30439321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials.
    Sinha P; Delucchi KL; McAuley DF; O'Kane CM; Matthay MA; Calfee CS
    Lancet Respir Med; 2020 Mar; 8(3):247-257. PubMed ID: 31948926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying vital sign trajectories to predict 28-day mortality of critically ill elderly patients with acute respiratory distress syndrome.
    Li M; Liu F; Yang Y; Lao J; Yin C; Wu Y; Yuan Z; Wei Y; Tang F
    Respir Res; 2024 Jan; 25(1):8. PubMed ID: 38178157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.